Structured evidence table for Flaxseed Lipid Markers Meta-Analysis, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Flaxseed Lipid Markers Meta-Analysis | Nonalcoholic fatty liver disease (NAFLD), recently defined as metabolic-associated fatty liver disease (MAFLD), when fat accumulates in hepatic tissues due to evident causes such as viral hepatitis, alcohol use, or medications [],]. | 4 | El Rabey Haddad A. (2026) | Flaxseed oil and probiotics protect against induced nonalcoholic fatty liver disease (NAFLD) in male rats |
| Flaxseed Lipid Markers Meta-Analysis | NAFLD could be a risk factor for the incidence of another metabolic syndrome, not only one []. | 4 | El Rabey Haddad A. (2026) | Flaxseed oil and probiotics protect against induced nonalcoholic fatty liver disease (NAFLD) in male rats |
| Flaxseed Lipid Markers Meta-Analysis | They aid in the determination of inflammation and change the function of vascular and carcinogen biomarkers, thus reducing the coronary heart disease (CHD) risk (CVD) and cancer. | 4 | El Rabey Haddad A. (2026) | Flaxseed oil and probiotics protect against induced nonalcoholic fatty liver disease (NAFLD) in male rats |
| Flaxseed Lipid Markers Meta-Analysis | 1 2 3 4 5 Recently, the etiology of chronic hepatic diseases has changed due to the decrease of viral hepatitis and the growing new epidemic of a wide range of metabolic complaints like steatosis, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) [],]. | 4 | El Rabey Haddad A. (2026) | Flaxseed oil and probiotics protect against induced nonalcoholic fatty liver disease (NAFLD) in male rats |
Source documents